Brian Armstrong
Overview
Explore the profile of Brian Armstrong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saftics A, Purnell B, Beres B, Thompson S, Jiang N, Ghaeli I, et al.
Anal Chem
. 2025 Jan;
97(3):1654-1664.
PMID: 39804668
Extracellular vesicles (EVs), membrane-encapsulated nanoparticles shed from all cells, are tightly involved in critical cellular functions. Moreover, EVs have recently emerged as exciting therapeutic modalities, delivery vectors, and biomarker sources....
2.
Mirzapoiazova T, Tseng L, Mambetsariev B, Li H, Lou C, Pozhitkov A, et al.
iScience
. 2024 Jul;
27(6):110132.
PMID: 38993482
Although up to 80% small cell lung cancer (SCLC) patients' response is good for first-line chemotherapy regimen, most patients develop recurrence of the disease within weeks to months. Here, we...
3.
Yu W, Herries A, Edwards T, Armstrong B, Joannes-Boyau R
PeerJ
. 2024 Jul;
12:e17478.
PMID: 38952976
Bolt's Farm is the name given to a series of non-hominin bearing fossil sites that have often been suggested to be some of the oldest Pliocene sites in the Cradle...
4.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, et al.
NPJ Precis Oncol
. 2024 Jun;
8(1):135.
PMID: 38898200
We conducted spatial immune tumor microenvironment (iTME) profiling using formalin-fixed paraffin-embedded (FFPE) samples of 25 KRAS-mutated non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs), including 12...
5.
Wolfe D, Arangies E, David G, Armstrong B, Scocca T, Fedler J, et al.
Clin Infect Dis
. 2024 May;
79(4):928-935.
PMID: 38804702
In response to the coronavirus disease 2019 (COVID-19) pandemic, vaccines were quickly and successfully developed and deployed, saving millions of lives globally. While first-generation vaccines are safe and effective in...
6.
Tajima T, Martinez O, Bernstein D, Boyd S, Gratzinger D, Lum G, et al.
Pediatr Transplant
. 2024 Apr;
28(4):e14763.
PMID: 38682750
Background: Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD) is the most common malignancy in children after transplant; however, difficulties for early detection may worsen the prognosis. Methods: The prospective, multicenter,...
7.
Sriram K, Qi Z, Yuan D, Malhi N, Liu X, Calandrelli R, et al.
Elife
. 2024 Jan;
13.
PMID: 38251974
Chromatin-associated RNAs (caRNAs) form a relatively poorly recognized layer of the epigenome. The caRNAs reported to date are transcribed from the nuclear genome. Here, leveraging a recently developed assay for...
8.
Govindarajan A, Salgia N, Li H, Castro D, Mirzapoiazova T, Armstrong B, et al.
Front Immunol
. 2023 Aug;
14:1182581.
PMID: 37638025
Objective: To characterize and further compare the immune cell populations of the tumor microenvironment (TME) in both clear cell and papillary renal cell carcinoma (RCC) using heavy metal-labeled antibodies in...
9.
Rao M, Amouzgar M, Harden J, Lapasaran M, Trickey A, Armstrong B, et al.
Cell Rep Med
. 2023 Aug;
4(8):101147.
PMID: 37552988
Solid organ transplant remains a life-saving therapy for children with end-stage heart, lung, liver, or kidney disease; however, ∼33% of allograft recipients experience acute rejection within the first year after...
10.
Martinez O, Krams S, Robien M, Lapasaran M, Arvedson M, Reitsma A, et al.
Am J Transplant
. 2023 Feb;
23(5):611-618.
PMID: 36796762
Epstein-Barr virus (EBV)-positive posttransplant lymphoproliferative disorder (PTLD) results in significant morbidity and mortality in pediatric transplant recipients. Identifying individuals at an increased risk of EBV-positive PTLD could influence clinical management...